2-Seattle Genetics

Welcome to our virtual exhibit booth!

About Us

Seattle Genetics, Inc. discovers, develops and commercializes novel medicines for cancer. For more information, visit www.seattlegenetics.com

VIRTUAL BOOTH STAFFING

M. Lucille Bodt RN BSN mbodt@seagen.com
Sr. Oncology Account Manager-ADCETRIS

Edilson Muniz – emuniz@seagen.com
Sr. Oncology Account Manager-TUKYSA

Lori Summerson– lsummerson@seagen.com
Sr. Oncology Account Manager-PADCEV

Click the links below for more info.

• ADCETRIS (brentuximab vedotin) for injection Prescribing Information, including BOXED WARNING
• Request a Rep to Learn More About ADCETRIS
• ADCETRIS Core Visual Aid
• ADCETRIS 5 year ECHELON-1 update

• TUKYSA (tucatinib) tablets Prescribing Information
• TUKYSA HER2CLIMB Reprint Carrier
• Request a Rep to Learn More About TUKYSA
• TUKYSA Dosing and Administration Guide

PADCEV® and the PADCEV logo are registered trademarks jointly owned by Agensys, Inc. and Seattle Genetics, Inc.

• PADCEV (enfortumab vedotin-ejfv) Prescribing Information
• PADCEV HCP Homepage
• PADCEV (enfortumab vedotin-ejfv) Dosing & Administration Guide